Dr. Patrick Hemmons travelled to Seattle, Wash., to get an RSV shot for his daughter. He says he hopes to see ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

Gateway Investment Advisers LLC cut its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 35.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

Funding for climate tech has contracted in recent years. What makes Gothenburg so unique in its ability to fund, scale and ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...

AstraZeneca faces significant challenges amid Chinese investigation and ongoing investor lawsuit regarding alleged misconduct ...

Three years ago in April, Jamie suffered a catastrophic bleed on the brain after being given the AstraZeneca Covid vaccine.

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...